心衰患者的个性化肾功能监测和干预:肾衰-心衰项目中共同设计护理途径的方案。

IF 2 Q2 PRIMARY HEALTH CARE
BJGP Open Pub Date : 2025-08-21 DOI:10.3399/BJGPO.2025.0099
Suzy C Hargreaves, Christopher J Armitage, Benjamin C Brown, Dawn Dowding, Jennifer Downing, Mark Goodall, Alison Gummery, Carolyn Lees, Emma Sowden, Nefyn H Williams, Bridget Young, Munir Pirmohamed
{"title":"心衰患者的个性化肾功能监测和干预:肾衰-心衰项目中共同设计护理途径的方案。","authors":"Suzy C Hargreaves, Christopher J Armitage, Benjamin C Brown, Dawn Dowding, Jennifer Downing, Mark Goodall, Alison Gummery, Carolyn Lees, Emma Sowden, Nefyn H Williams, Bridget Young, Munir Pirmohamed","doi":"10.3399/BJGPO.2025.0099","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Heart failure affects almost one million people in the UK and is increasing in prevalence. Many drugs used to treat heart failure impair renal function and can lead to hospitalisation. Adverse drug problems can be partially mitigated through regular renal monitoring and optimising of drug dose and choice to prevent deterioration of kidney function. This protocol describes part of a wider research programme: personalising <b>renal</b> function monitoring and interventions in people living with <b>h</b>eart <b>f</b>ailure (RENAL-HF).</p><p><strong>Aim: </strong>The aim of RENAL-HF is to develop improved processes in primary care to manage kidney health in people living with heart failure.</p><p><strong>Method: </strong>The protocol covers gathering views of healthcare professionals, patients and carers, to co-develop a care pathway for use in primary care. Using a mixed methods approach, the work comprises six stages: 1) understanding current practice of optimising heart failure treatment while preserving renal function, 2) co-designing a care pathway including personalised renal function monitoring, thresholds for intervention and clinical guidelines, 3) decision-making to identify elements that will support the care pathway, 4) developing training materials for primary care to enable use of the care pathway, 5) testing the useability of the prototype care pathway, and 6) a feasibility and acceptability study to inform the pre-clinical development and usability of the care pathway ahead of a cluster randomised control trial.</p><p><strong>Conclusion: </strong>All stages will elicit evidence from primary care practices, practitioners, and patients with which to assess and refine the care pathway. The evidence will inform how algorithm-guided individualised treatment can be implemented to improve outcomes of patients with heart failure.</p>","PeriodicalId":36541,"journal":{"name":"BJGP Open","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Personalising renal function monitoring and interventions in people living with heart failure: protocol for co-designing a care pathway in the RENAL-HF programme.\",\"authors\":\"Suzy C Hargreaves, Christopher J Armitage, Benjamin C Brown, Dawn Dowding, Jennifer Downing, Mark Goodall, Alison Gummery, Carolyn Lees, Emma Sowden, Nefyn H Williams, Bridget Young, Munir Pirmohamed\",\"doi\":\"10.3399/BJGPO.2025.0099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Heart failure affects almost one million people in the UK and is increasing in prevalence. Many drugs used to treat heart failure impair renal function and can lead to hospitalisation. Adverse drug problems can be partially mitigated through regular renal monitoring and optimising of drug dose and choice to prevent deterioration of kidney function. This protocol describes part of a wider research programme: personalising <b>renal</b> function monitoring and interventions in people living with <b>h</b>eart <b>f</b>ailure (RENAL-HF).</p><p><strong>Aim: </strong>The aim of RENAL-HF is to develop improved processes in primary care to manage kidney health in people living with heart failure.</p><p><strong>Method: </strong>The protocol covers gathering views of healthcare professionals, patients and carers, to co-develop a care pathway for use in primary care. Using a mixed methods approach, the work comprises six stages: 1) understanding current practice of optimising heart failure treatment while preserving renal function, 2) co-designing a care pathway including personalised renal function monitoring, thresholds for intervention and clinical guidelines, 3) decision-making to identify elements that will support the care pathway, 4) developing training materials for primary care to enable use of the care pathway, 5) testing the useability of the prototype care pathway, and 6) a feasibility and acceptability study to inform the pre-clinical development and usability of the care pathway ahead of a cluster randomised control trial.</p><p><strong>Conclusion: </strong>All stages will elicit evidence from primary care practices, practitioners, and patients with which to assess and refine the care pathway. The evidence will inform how algorithm-guided individualised treatment can be implemented to improve outcomes of patients with heart failure.</p>\",\"PeriodicalId\":36541,\"journal\":{\"name\":\"BJGP Open\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BJGP Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3399/BJGPO.2025.0099\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PRIMARY HEALTH CARE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJGP Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3399/BJGPO.2025.0099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 0

摘要

背景:在英国,心力衰竭影响着近100万人,并且患病率正在上升。许多用于治疗心力衰竭的药物会损害肾功能,并可能导致住院。通过定期监测肾脏,优化药物剂量和选择,以防止肾功能恶化,可以部分减轻药物不良问题。本协议描述了一个更广泛的研究项目的一部分:心力衰竭患者的个性化肾功能监测和干预。目的:肾功能衰竭-心力衰竭的目的是开发改进的初级保健流程,以管理心力衰竭患者的肾脏健康。方法:该协议包括收集医疗保健专业人员、患者和护理人员的意见,以共同制定用于初级保健的护理途径。采用混合方法,工作包括六个阶段:1)了解目前在保持肾功能的同时优化心力衰竭治疗的实践;2)共同设计一个护理途径,包括个性化的肾功能监测、干预阈值和临床指南;3)制定决策,以确定支持护理途径的要素;4)为初级保健开发培训材料,使护理途径能够使用;5)测试原型护理途径的可用性。6)可行性和可接受性研究,在集群随机对照试验之前为临床前开发和护理途径的可用性提供信息。结论:所有阶段都将从初级保健实践、从业人员和患者那里获得证据,以评估和完善护理途径。证据将告知如何实施算法指导的个体化治疗,以改善心力衰竭患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Personalising renal function monitoring and interventions in people living with heart failure: protocol for co-designing a care pathway in the RENAL-HF programme.

Background: Heart failure affects almost one million people in the UK and is increasing in prevalence. Many drugs used to treat heart failure impair renal function and can lead to hospitalisation. Adverse drug problems can be partially mitigated through regular renal monitoring and optimising of drug dose and choice to prevent deterioration of kidney function. This protocol describes part of a wider research programme: personalising renal function monitoring and interventions in people living with heart failure (RENAL-HF).

Aim: The aim of RENAL-HF is to develop improved processes in primary care to manage kidney health in people living with heart failure.

Method: The protocol covers gathering views of healthcare professionals, patients and carers, to co-develop a care pathway for use in primary care. Using a mixed methods approach, the work comprises six stages: 1) understanding current practice of optimising heart failure treatment while preserving renal function, 2) co-designing a care pathway including personalised renal function monitoring, thresholds for intervention and clinical guidelines, 3) decision-making to identify elements that will support the care pathway, 4) developing training materials for primary care to enable use of the care pathway, 5) testing the useability of the prototype care pathway, and 6) a feasibility and acceptability study to inform the pre-clinical development and usability of the care pathway ahead of a cluster randomised control trial.

Conclusion: All stages will elicit evidence from primary care practices, practitioners, and patients with which to assess and refine the care pathway. The evidence will inform how algorithm-guided individualised treatment can be implemented to improve outcomes of patients with heart failure.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BJGP Open
BJGP Open Medicine-Family Practice
CiteScore
5.00
自引率
0.00%
发文量
181
审稿时长
22 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信